| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/30/2009 | WO2009054965A1 Salts of n- (6-chloro-9h-pyrido [3,4-b] ind0l-8-yl) -4- [2- (2, 6-dimethyl-4-morpholinyl) -2-0x0e thyl] -6, 6-dimethyl-morpholinecarboxamide |
| 04/30/2009 | WO2009054864A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/30/2009 | WO2009054497A1 Novel compound having affinity for amyloid |
| 04/30/2009 | WO2009054496A1 Novel compound having affinity for amyloid |
| 04/30/2009 | WO2009054401A1 Anti-viral agent comprising heterocyclic aromatic compound as active ingredient |
| 04/30/2009 | WO2009053716A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/30/2009 | WO2009039362A3 Chiral synthesis of diazepinoquinolines |
| 04/30/2009 | WO2009030725A3 Azaindoles as inhibitors of soluble adenylate cyclase |
| 04/30/2009 | WO2009027077A8 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof |
| 04/30/2009 | WO2009026422A3 Treatment of central nervous system disorders |
| 04/30/2009 | WO2009011871A3 Thiadiazole modulators of pkb |
| 04/30/2009 | WO2008126123A3 Water-soluble coronene derivatives active as inhibitors of telomerase |
| 04/30/2009 | WO2007058850A3 Inhibitors of akt activity |
| 04/30/2009 | WO2007050810A3 Fluorogenic probes for reactive oxygen species |
| 04/30/2009 | WO2006055879A3 Novel phosphorous containing steroid mimics |
| 04/30/2009 | US20090111851 Antimicrobial Quinolones, Their Compositions and Uses |
| 04/30/2009 | US20090111847 Preparation method and use of compounds having high insecticidal activities |
| 04/30/2009 | US20090111842 Spirocyclic cyclohexane compounds with analgesic activity |
| 04/30/2009 | US20090111825 Thiophene 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111806 Azaquinolone based compounds exhibiting prolyl hydroxylase Inhibitory activity, compositions, and uses thereof |
| 04/30/2009 | US20090111805 Bicyclic heteroaromatic derivatives useful as anticancer agents |
| 04/30/2009 | CA2704052A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/30/2009 | CA2704027A1 Novel compound having affinity for amyloid |
| 04/30/2009 | CA2704008A1 New tetracyclic compounds |
| 04/30/2009 | CA2703649A1 Novel compound having affinity for amyloid |
| 04/30/2009 | CA2703203A1 Bicyclic heterocycle derivatives and methods of use thereof |
| 04/30/2009 | CA2703138A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/30/2009 | CA2702126A1 Heterocycle amide t-type calcium channel antagonists |
| 04/30/2009 | CA2701286A1 Carbacephem .beta.-lactam antibiotics |
| 04/29/2009 | EP2053051A1 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element |
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease |
| 04/29/2009 | EP2051975A2 Substituted prolinamides, production thereof and their use as drugs |
| 04/29/2009 | EP1838707B1 Novel pyrrolodihydroisoquinolines as pde10 inhibitors |
| 04/29/2009 | EP1542994B1 Novel oxazole compounds as transforming growth factor (tgf) inhibitor |
| 04/29/2009 | EP1539764B1 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists. |
| 04/29/2009 | EP1066286B1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 04/29/2009 | CN101421269A Inhibitors of tyrosine kinases and uses thereof |
| 04/29/2009 | CN101421268A Pyrazoloquinolones as potent PARP inhibitors |
| 04/29/2009 | CN101421267A Process for the preparation of pyridine heterocycle CGRP antagonist intermediate |
| 04/29/2009 | CN101421266A Process for the preparation of CGRP antagonist |
| 04/29/2009 | CN101421265A Thiazole compounds as protein kinase b (pkb) inhibitors |
| 04/29/2009 | CN101421257A Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 04/29/2009 | CN100482663C Novel fused triazolones and the uses thereof |
| 04/29/2009 | CN100482662C Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 04/29/2009 | CN100482659C Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
| 04/29/2009 | CN100482658C Process for preparing optically pure active compounds |
| 04/29/2009 | CN100482225C Novel heterocyclic compounds which are active as inhibitors of beta-lactamases |
| 04/28/2009 | US7524959 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/28/2009 | US7524956 Hemisynthetic method and new compounds |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524860 Antibacterial agents |
| 04/28/2009 | US7524859 Treating hyperproliferative disorders such as gastrointestinal cancer, breast cancer, head cancer, or neck cancer; N-(4-trifluoromethoxyphenyl) 3-[(quinolin-4-ylmethyl)amino]thiophene-2-carboxamide |
| 04/28/2009 | US7524858 Substituted pyrroline kinase inhibitors |
| 04/28/2009 | US7524857 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents |
| 04/28/2009 | US7524853 Cyclohexylthiophenepyrimidinone, cyclohexylpyrrolylpyrimidinone or cyclohexylfuranylpyrimidinone compounds for use in the treatment of a steroid hormone dependent diseases; inhibitor of 17 beta -hydroxysteroid dehydrogenase enzymes |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | US7524847 Inhibit Dipeptidyl peptidase-IV; 7-(2-Butynyl)-3-methyl-3,7-dihydropurine-2,6-dione; suppress degradation of Glucagon-Like Peptide-1; enhance action of incretin; facilitate insulin secretion from pancreatic beta -cells due to glucose stimulus; postchallenge hyperglycemia, improved oral glucose tolerance |
| 04/28/2009 | US7524845 Chemokine receptor 1 (CCR1) antagonists; 1-[4-phenylpiperazin-1-yl]-2-pyrazolo[4,3-b]pyridin-1-yl-ethanone compounds; inflammatory condition or autoimmune disorders such as rheumatoid arthritis, multiple sclerosis, transplant rejection, restenosis, dermatitis |
| 04/28/2009 | US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 04/28/2009 | US7524484 Delivery of diphenhydramine through an inhalation route |
| 04/28/2009 | CA2472954C Aza-arylpiperazines |
| 04/28/2009 | CA2380074C Novel amide derivatives |
| 04/23/2009 | WO2009052237A1 Inhibitors of c-fms kinase |
| 04/23/2009 | WO2009052065A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 04/23/2009 | WO2009052063A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
| 04/23/2009 | WO2009051580A1 C7-substituted camptothecin analogs |
| 04/23/2009 | WO2009051504A1 Benzo- and pyridopyridazinones with analgesic and antiinflammatory activity |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |
| 04/23/2009 | WO2009051210A1 Method for producing pyrazole fused ring derivative |
| 04/23/2009 | WO2009050348A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | WO2009050237A1 Cgrp antagonists |
| 04/23/2009 | WO2009050235A1 Cgrp antagonists |
| 04/23/2009 | WO2009050234A1 Cgrp antagonists |
| 04/23/2009 | WO2009050232A1 Cgrp antagonists |
| 04/23/2009 | WO2009050183A2 Imidazo [1, 2-a] pyridine derivatives useful as alk inhibitors |
| 04/23/2009 | WO2009049851A1 Spiroheterocyclic pyrrolidine dione derivatives useful as pesticides |
| 04/23/2009 | WO2009027820A3 Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
| 04/23/2009 | WO2009007751A3 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 04/23/2009 | WO2009001060A3 Use of compounds for preparing anti-tuberculosis agents |
| 04/23/2009 | WO2008152014A3 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases |
| 04/23/2009 | WO2008008704A3 Inhibitors of cyclic nucleotide synthesis and their use for therapy of various diseases |
| 04/23/2009 | WO2007138466A3 Pharmaceutical compositions comprising meloxicam and tramadol combination |
| 04/23/2009 | WO2007096807A3 Process for the preparation of zaleplon and an intermediate thereof |
| 04/23/2009 | US20090105479 4-Oxo-1-3-Substituted Phenyl-1,4-Dihydro-1,8-Napthyridene-3-Carboxamide Phosphodiesterase-4 Inhibitor and a Method of Preparing Same |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105310 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use |
| 04/23/2009 | US20090105296 Inhibitors of c-fms kinase |
| 04/23/2009 | US20090105295 Hydroxylamine substituted imidazoquinolines |
| 04/23/2009 | US20090105293 Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 04/23/2009 | US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/23/2009 | US20090105283 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| 04/23/2009 | US20090105263 Heterobicyclic compounds as glucokinase activators |
| 04/23/2009 | US20090105259 Acyclic 1,4-Diamines and Uses Thereof |
| 04/23/2009 | US20090105255 Glucokinase activators |
| 04/23/2009 | US20090105242 Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases |
| 04/23/2009 | US20090105233 Serine-threonine protein kinase and parp modulators |
| 04/23/2009 | US20090105230 Anti-inflammatory medicaments |
| 04/23/2009 | US20090105229 Purine derivatives as kinase inhibitors |
| 04/23/2009 | US20090105226 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans |